Robin Hallett

SVP, Discovery & Translational Sciences at POINT Biopharma

Robin is responsible for preclinical development at POINT. He is an experienced leader in drug discovery and development with broad expertise from early discovery through to first-in-human studies. Previously, Robin was Head of Translational Sciences at Northern Biologics, which focused on developing first-in-class biologics for the treatment of solid tumors. Robin obtained his Ph.D. in biochemistry from McMaster University and completed post-doctoral training at the Hospital for Sick Children in cancer biology.

Links

Previous companies

The Hospital for Sick Children logo
McMaster University logo

Timeline

  • SVP, Discovery & Translational Sciences

    Current role

  • Senior Director, Preclinical

  • VP, Discovery & Translational Sciences

View in org chart